@article{a81a0f048c464e1da83362cce2627e91,
title = "Reducing valproate use in women with epilepsy",
keywords = "Abnormalities, Drug-Induced/prevention & control, Adolescent, Adult, Anticonvulsants/adverse effects, Drug Utilization, Epilepsy/drug therapy, Female, Humans, Pharmacovigilance, Pregnancy, Risk Assessment, Valproic Acid/adverse effects, Young Adult",
author = "Reetta K{\"a}lvi{\"a}inen and Sabine Straus and Dogne, {Jean Michel} and Serge Bakchine and Manuel Haas",
note = "Funding Information: The views presented are those of the authors and should not be understood or quoted as being made on behalf of the European Medicines Agency or its scientific committees. MH is an employee of the European Medicines Agengy. RK reports grants from the Academy of Finland, Vaajasalo Foundation, and Saastamoinen Foundation, costs for her institution and academic research from Eisai and UCB Pharma paid to her insitution, and personal fees from Eisai, UCB pharma, Orion Pharma, Sage Therapeutics, Fenno Medical, Takeda, and GW Pharmaceuticals. All other authors declare no competing interests. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",
year = "2018",
month = jul,
day = "1",
doi = "10.1016/S1474-4422(18)30172-8",
language = "English",
volume = "17",
pages = "580--581",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "The Lancet Publishing Group",
number = "7",
}